Clostebol caproate: Difference between revisions
CSV import |
CSV import |
||
| Line 30: | Line 30: | ||
[[Category:Testosterone]] | [[Category:Testosterone]] | ||
{{stub}} | {{stub}} | ||
<gallery> | |||
File:Clostebol_caproate.svg|Chemical structure of Clostebol caproate | |||
File:Clostebol_caproate_molecule_ball.png|Ball-and-stick model of Clostebol caproate | |||
</gallery> | |||
Latest revision as of 01:47, 18 February 2025
Clostebol caproate is a synthetic androgen and anabolic steroid and a derivative of testosterone. It is the caproate ester of clostebol (chlorotestosterone), which is an androgen that has been sold under the brand names Megagrisevit and Steranabol among others.
Pharmacology[edit]
Clostebol caproate is a prodrug of clostebol. Like other AAS, clostebol is an agonist of the androgen receptor (AR). It is not a substrate for 5α-reductase and is a poor substrate for 3α-hydroxysteroid dehydrogenase (3α-HSD), and therefore shows a high ratio of anabolic to androgenic activity.
Chemistry[edit]
Clostebol caproate, also known as 4-chlorotestosterone 17β-caproate, is a synthetic androstane steroid and a derivative of testosterone. It is the C17β caproate (hexanoate) ester of clostebol (4-chlorotestosterone), which is testosterone with a chlorine atom at the C4 position.
History[edit]
Clostebol caproate was first described in 1962 and was introduced for medical use by 1964.
Society and culture[edit]
Clostebol caproate has been used in bodybuilding and has been marketed for veterinary use.
See also[edit]
References[edit]
<references />


